INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
HOUSE PTR/PurchaseVerified data

Gilbert Ray Cisneros, Jr. bought ATRC

Self · AtriCure, Inc. · AtriCure, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Mar 3, 2026
Disclosed
Apr 7, 2026
Disclosure timeline35 days from execution to publication · legal deadline 45 days
Mar 3 executedApr 7, 2026 disclosed

ATRC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
28/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing+4 / 15

    Disclosed 35 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ATRC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    15
    PS
    Privitera SalvatoreChief Technical Officer
    ATRCAtriCure, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$546K
    8,404 sh
    		Nov 4, 2026Nov 5, 2026
    traded Nov 4, 2026
    		+1dSEC FORM 4

    Evidence

    27
    Gilbert Ray Cisneros, Jr.DSelf
    ATRCAtriCure, Inc.
    Partial sale
    		SELL$1,001 – $15KSep 29, 2026Oct 12, 2026
    traded Sep 29, 2026
    		+13dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    ATRCAtriCure, Inc.
    Purchase
    		BUY$1,001 – $15KAug 20, 2026Sep 10, 2026
    traded Aug 20, 2026
    		+21dHOUSE PTR

    Evidence

    31
    DS
    Dahlquist Karl S.Chief Legal Officer
    ATRCAtriCure, Inc.
    Open-market sale
    		SELL$458K
    9,370 sh
    		Aug 24, 2026Aug 26, 2026
    traded Aug 24, 2026
    		+2dSEC FORM 4

    Evidence

    17
    NS
    Nachman ShlomoDirector
    ATRCAtriCure, Inc.
    Grant or award
    		A—
    6,144 sh
    		May 18, 2026May 20, 2026
    traded May 18, 2026
    		+2dSEC FORM 4

    Evidence

    17
    TH
    Telman Deborah HDirector
    ATRCAtriCure, Inc.
    Grant or award
    		A—
    6,144 sh
    		May 18, 2026May 20, 2026
    traded May 18, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034285

    Timestamps

    Event (reported)
    Mar 3, 2026
    Published
    Apr 7, 2026
    Ingested by INSIDER
    Nov 5, 06:47 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Gilbert Ray Cisneros, Jr.
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    AtriCure, Inc. - Common Stock
    Ticker
    ATRC
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Mar 3, 2026
    Notification date (reported)
    Apr 6, 2026
    Days from execution to publication
    35

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Gilbert Ray Cisneros, Jr. reported a purchase of AtriCure, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Gilbert Ray Cisneros, Jr.bioguide:C001123
    Issuer
    AtriCure, Inc.cik:0001323885

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.